More than one in three people will develop some sort of cancer during their lifetime, according to the NHS. The four most common types of the disease in the UK are breast cancer, lung cancer, prostate cancer and bowel cancer. However, there are over 200 different types of cancer, all with varying symptoms. You may think symptoms of a serious disease like cancer would be obvious – we all know the appearance of a lump, for example, should be checked out.
Oncimmune (LON:ONC) is a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. Oncimmune is changing how clinicians, researchers and patients view, diagnose and treat cancer. Our technology detects evidence of the body’s natural response to cancer, enabling detection 4 years or more before standard clinical diagnosis. Our tests facilitate clinical decision-making and are complementary to diagnostic technologies, making them valuable additions to established and new care pathways. We partner with leading developers and distributors to make our technology available globally.